Outcome of Second Line Treatment of Recurrent High- Grade Glioma by re-Irradiation or Bevacizumab-based Chemotherapy: A Cross Sectional Study.

Kazem AnvariMehri ShahabadiJames S WelshSeyed Alireza JavadiniaElham Zarei
Published in: Asian Pacific journal of cancer prevention : APJCP (2023)
The PFS is similar after the second line treatment of recurrent primary central nervous system malignancies either by re-irradiation or bevacizumab-based chemotherapy.